Friday, April 23, 2010

Healthcare's impact on Pharma companies

According to Drug Store News, Merck will see significant losses from the passage of the healthcare bill. They cite :

Medicaid rebates would cause it to incur costs of $35 million in first quarter 2010 and $170 million for the full year, while the elimination of a tax benefit for retiree prescription drug coverage would cause it to take a non-cash charge in the first quarter of $150 million.

Event through this, they project growth through the year 2012. Is your company facing the same thing when it comes to healthcare reform?

No comments: